Peptide record

TPDB11247

Antibacterial Anticancer Antifungal Antiparasitic Toxicity standard
30 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB11247
Antibacterial Anticancer Antifungal Antiparasitic Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia AntiCP 2.0 SATPdb dbACP iACP-DRLF Antifungipept CAFPdb ToxinPred 3.0
standard
No
A 30-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
KFFRKLKKSVKKRAKEFFKKPRVIGVSIPF
Physicochemical Analysis
C176H290N48O35
NDCQHMTWY
K
3638.54
12.21
12
1
12
+11
7.74
-0.537
71.33
Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min
0
0.00
2
Residue Composition
number
1
A
3
R
0
N
0
D
0
C
1
E
0
Q
1
G
0
H
2
I
1
L
9
K
0
M
5
F
2
P
2
S
0
T
0
W
0
Y
3
V
Amino Acid Distribution
A: 1 R: 3 N: 0 D: 0 C: 0 E: 1 Q: 0 G: 1 H: 0 I: 2 L: 1 K: 9 M: 0 F: 5 P: 2 S: 2 T: 0 W: 0 Y: 0 V: 3
Chemical Descriptors
30
C176H290N48O35
3638.54
12.21
+11
7.74
-0.537
Evidence Records 15 records
Evidence 1 Activity

Activity

MIC
Antibacterial
2.3 µM

Target

Escherichia coli ATCC25922

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against E. coli ATCC25922 (MIC 2.3 uM), P. aeruginosa ATCC278953 (MIC 1.2 uM), S. aureus ATCC2592, and C. albicans (MIC 4.7 uM).
Evidence 2 Activity

Activity

MIC
Antibacterial
1.2 µM

Target

Pseudomonas aeruginosa ATCC278953

Source & Reference

dbAMP DRAMP

Other

Active against E. coli ATCC25922 (MIC 2.3 uM), P. aeruginosa ATCC278953 (MIC 1.2 uM), S. aureus ATCC2592, and C. albicans (MIC 4.7 uM). The peptide and its lysine 16 variant
Evidence 3 Activity

Activity

MIC
Antibacterial
4.7 µM

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

li ATCC25922 (MIC 2.3 uM), P. aeruginosa ATCC278953 (MIC 1.2 uM), S. aureus ATCC2592, and C. albicans (MIC 4.7 uM). The peptide and its lysine 16 variant also possesses anticancer effects (Tian Y et al. 2
Evidence 4 Activity

Activity

MIC
Antifungal
2.3 µM

Target

Escherichia coli ATCC25922

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against E. coli ATCC25922 (MIC 2.3 uM), P. aeruginosa ATCC278953 (MIC 1.2 uM), S. aureus ATCC2592, and C. albicans (MIC 4.7 uM).
Evidence 5 Activity

Activity

MIC
Antifungal
1.2 µM

Target

Pseudomonas aeruginosa ATCC278953

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against E. coli ATCC25922 (MIC 2.3 uM), P. aeruginosa ATCC278953 (MIC 1.2 uM), S. aureus ATCC2592, and C. albicans (MIC 4.7 uM). The peptide and its lysine 16 variant
Evidence 6 Activity

Activity

MIC
Antifungal
4.7 µM

Target

Candida albicans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

li ATCC25922 (MIC 2.3 uM), P. aeruginosa ATCC278953 (MIC 1.2 uM), S. aureus ATCC2592, and C. albicans (MIC 4.7 uM). The peptide and its lysine 16 variant also possesses anticancer effects (Tian Y et al. 2
Evidence 7 Activity

Activity

MIC
Antiparasitic
2.3 µM

Target

Escherichia coli ATCC25922

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against E. coli ATCC25922 (MIC 2.3 uM), P. aeruginosa ATCC278953 (MIC 1.2 uM), S. aureus ATCC2592, and C. albicans (MIC 4.7 uM).
Evidence 8 Activity

Activity

MIC
Antiparasitic
1.2 µM

Target

Pseudomonas aeruginosa ATCC278953

Source & Reference

DRAMP

Other

Active against E. coli ATCC25922 (MIC 2.3 uM), P. aeruginosa ATCC278953 (MIC 1.2 uM), S. aureus ATCC2592, and C. albicans (MIC 4.7 uM). The peptide and its lysine 16 variant
Evidence 9 Activity

Activity

MIC
Antiparasitic
4.7 µM

Target

Candida albicans

Source & Reference

DRAMP

Other

li ATCC25922 (MIC 2.3 uM), P. aeruginosa ATCC278953 (MIC 1.2 uM), S. aureus ATCC2592, and C. albicans (MIC 4.7 uM). The peptide and its lysine 16 variant also possesses anticancer effects (Tian Y et al. 2
Evidence 10 Activity

Activity

Toxicity
Hemolytic Cytotoxic
- | NA | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Snake cathelicidin from Bungarus fasciatus is a potent peptide antibiotics. | PLoS One | 2008
Evidence 11 Activity

Activity

1% Hemolysis
Toxicity
100 µM
Hemolytic Cytotoxic
1% Hemolysis | 100 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Potent antimicrobial peptides with selectivity for Bacillus anthracis over human erythrocytes. | Int J Antimicrob Agents | 2011
Evidence 12 Activity

Activity

10% Hemolysis
Toxicity
>320 µg/mL
Hemolytic Cytotoxic
10% Hemolysis | >320 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
A Designed Tryptophan- and Lysine/Arginine-Rich Antimicrobial Peptide with Therapeutic Potential for Clinical Antibiotic-Resistant Candida albicans Vaginitis. | J Med Chem | 2016
Evidence 13 Activity

Activity

50% Hemolysis
Toxicity
>320 µg/mL
Hemolytic Cytotoxic
50% Hemolysis | >320 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
A Designed Tryptophan- and Lysine/Arginine-Rich Antimicrobial Peptide with Therapeutic Potential for Clinical Antibiotic-Resistant Candida albicans Vaginitis. | J Med Chem | 2016
Evidence 14 Activity

Activity

7% Hemolysis
Toxicity
320 µg/mL
Hemolytic Cytotoxic
7% Hemolysis | 320 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
A Designed Tryptophan- and Lysine/Arginine-Rich Antimicrobial Peptide with Therapeutic Potential for Clinical Antibiotic-Resistant Candida albicans Vaginitis. | J Med Chem | 2016
Evidence 15 Activity

Activity

Toxicity
Hemolytic
Hemolytic_activity: [Ref.18795096]Non-hemolytic activity at 400 µg/ml against human red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
PLoS One. 2008 Sep 16 3(9):e3217.##Peptides. 2008 Oct 29(10):1685-1691.